Sygehus Lillebaelt — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Sygehus Lillebaelt appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15

Recruiting shown3

Roles2

SourceClinicalTrials.gov

Clinical trials

15 shown

Does Chronic Obstructive Lung Disease Influence the Cognitive FunctionNCT04458038 · lead sponsor · 2020-12-07

Prevalence of Unknown and Known Diabetes in Patients With Frozen ShoulderNCT01978886 · lead sponsor · 2013-12-01

Enhanced COPD Management in Suspected Lung Cancer PatientsNCT07543601 · collaborator · 2026-03-06

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 FractionsNCT07343349 · collaborator · 2025-12-15

A Multi-center Investigation of Family Health.NCT06433349 · collaborator · 2024-05-13

Optimising Mammography Screening Accuracy With Blood-based BiomarkersNCT07049822 · collaborator · 2025-11-24

ENROLLING_BY_INVITATION

Does the Sequence of Heart Failure Medication MatterNCT06637618 · collaborator · 2025-02-01

NOT_YET_RECRUITING

Protons vs. Photons for High-risk Prostate CancerNCT05350475 · collaborator · 2022-03-01

ACTIVE_NOT_RECRUITING

PRISMA-PET - Primary Staging of Prostate Cancer With PSMANCT05123300 · collaborator · 2021-10-04

Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid ArthritisNCT04842981 · collaborator · 2021-05-25

Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute ExacerbationNCT04223050 · collaborator · 2020-02-03

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking TechniqueNCT03847545 · collaborator · 2018-12-12

Chronic Inflammatory Disease, Lifestyle and Treatment ResponseNCT03173144 · collaborator · 2017-09-21

Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesNCT03214263 · collaborator · 2015-05-01

Secondary Breast Reconstruction With a Flap of Skin From the BackNCT02169011 · collaborator · 2013-09-01

Drugs studied in this sponsor's trials

3 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Sygehus Lillebaelt as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

dalfampridine1

sarilumab1

tocilizumab1

dalfampridine RxCUI 897018 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial sarilumab RxCUI 1923319 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tocilizumab RxCUI 612865 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator13

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.